Castle Biosciences, Inc.
General ticker "CSTL" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $640.6M (TTM average)
Castle Biosciences, Inc. follows the US Stock Market performance with the rate: 29.7%.
Estimated limits based on current volatility of 2.0%: low 39.32$, high 40.90$
Factors to consider:
- Total employees count: 761 (+24.8%) as of 2024
- Top business risk factors: Geopolitical risks, Economic downturns and volatility, Supply chain disruptions, Inflationary pressures, Regulatory and compliance
- Current price 12.0% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [18.05$, 35.37$]
- 2025-12-31 to 2026-12-31 estimated range: [15.75$, 31.55$]
Financial Metrics affecting the CSTL estimates:
- Positive: with PPE of 43.7 at the end of fiscal year the price was neutral
- Positive: -3.60 < Operating profit margin, % of 2.61
- Positive: 6.82 < Operating cash flow per share per price, % of 8.63
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 85.81 > 63.39
- Positive: Inventory ratio change, % of -1.10 <= -0.75
- Positive: -14.38 < Investing cash flow per share per price, % of -6.67
- Positive: Industry inventory ratio change (median), % of -0.79 <= -0.15
Short-term CSTL quotes
Long-term CSTL plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $137.04MM | $219.79MM | $332.07MM |
| Operating Expenses | $209.89MM | $287.76MM | $323.40MM |
| Operating Income | $-72.86MM | $-67.98MM | $8.67MM |
| Non-Operating Income | $3.95MM | $10.61MM | $12.89MM |
| Interest Expense | $0.02MM | $0.01MM | $0.58MM |
| R&D Expense | $44.90MM | $53.62MM | $52.04MM |
| Income(Loss) | $-68.90MM | $-57.37MM | $21.56MM |
| Taxes | $-1.77MM | $0.10MM | $3.32MM |
| Profit(Loss)* | $-67.14MM | $-57.47MM | $18.25MM |
| Stockholders Equity | $399.15MM | $391.27MM | $455.83MM |
| Inventory | $3.98MM | $7.94MM | $8.13MM |
| Assets | $447.33MM | $453.34MM | $531.24MM |
| Operating Cash Flow | $-41.66MM | $-5.63MM | $64.87MM |
| Capital expenditure | $5.63MM | $13.62MM | $28.33MM |
| Investing Cash Flow | $-166.54MM | $-16.18MM | $-50.14MM |
| Financing Cash Flow | $1.51MM | $-2.30MM | $6.14MM |
| Earnings Per Share** | $-2.58 | $-2.14 | $0.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.